No Data
No Data
Sun Pharma Signs Deal With Japan's Takeda to Commercialize Vonoprazan in India
Sun Pharmaceutical Industries (NSE:SUNPHARMA, BOM:524715) signed a non-exclusive patent licensing deal with Japan's Takeda Pharmaceutical (TYO:4502) to market Vonoprazan tablets of 10 mg and 20 mg dos
Top Gap Ups and Downs on Thursday: TMO, ACN, DHR and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Top Gap Ups and Downs on Tuesday: QCOM, MU, NEE and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Oppenheimer Cuts Ovid to Perform, Cites Uncertainty Over Lead Drug
Express News | Takeda Pharmaceutical Shares Are Trading Lower After the Company Announced Data From the Phase 3 ADVANCE-CIDP 3 Clinical Trial
Takeda Pharmaceutical Says Results of Phase 3 Trial Support Use of Hyqvia as Maintenance Treatment for CIDP
Takeda Pharmaceutical (TAK) said Tuesday that results of a phase 3 trial support the use of Hyqvia as maintenance treatment for chronic inflammatory demyelinating polyneuropathy or CIDP, an acquired,
TrytosaveabitOP : AC Immune Eligible for $2.1B in Potential Milestones
74137893 : too fast to catch
TrytosaveabitOP 74137893: IMO it’s not done! NFA
YYDW : There was another sudden surge like this; you just get covered when you enter